BMO Capital Maintains Outperform on Chemours, Raises Price Target to $25

BMO Capital maintains Chemours (NYSE:CC) with a Outperform and raises the price target from $23 to $25.

Benzinga · 11/07/2019 14:48

BMO Capital maintains Chemours (NYSE:CC) with a Outperform and raises the price target from $23 to $25.